|
ASP Drug Pricing Files January 2012 Update The files below contain the payment amounts that will be used to pay for Part B covered drugs for the first quarter of 2012. Comparing the first quarter of 2012 payment amounts with previous quarters reveals that, for the most part, average drug prices in the market remain relatively stable. On average, prices for the top Part B drugs decreased by 1.7 percent. For most of the higher volume drugs (35 out of the top 50), the prices changed 2 percent or less. Overall, the prices for 19 of the top 50 drugs decreased. In general, among the top drugs with a decrease, there are a number of competitive market factors at work – multiple manufacturers, alternative therapies, new products, recent generic entrants, or market shifts to lower priced products. CMS remains interested in ensuring continued beneficiary access to Part B covered drugs. We will continue to monitor trends in pricing, as reflected by the published ASP payment rates, as well as utilization within the Medicare community. Where applicable, the payment amounts in the quarterly ASP files are 106 percent of the Average Sales Price (ASP) calculated from data submitted by drug manufacturers. The quarter to quarter price changes are generally the result of updated data from the manufacturers of these drugs. The Medicare Part B payment limits for valid HCPCS codes that are not included in the quarterly ASP pricing files will be determined by the local Medicare contractor.
Page Last Modified: 12/15/2011 3:57:10 PM
Help with File Formats and Plug-Ins
Submit Feedback
|
